Diferencia entre revisiones de «Primary CNS lymphoma»
Sin resumen de edición |
Sin resumen de edición |
||
| Línea 30: | Línea 30: | ||
==See Also== | ==See Also== | ||
[[HIV - AIDS (main)]] | *[[HIV - AIDS (main)]] | ||
*[[HIV neurologic complications]] | |||
==External Links== | ==External Links== | ||
Revisión del 06:35 5 may 2017
Background
- AIDS defining malignancy that is strongly related to Epstein-Barr virus (EBV) infection
- Occurs with profound immunosuppression (CD4 counts <50cells/uL)
- Accounts for approximately 20 to 30% of CNS lesions in patients with AIDs
Clinical Features
- Can present with a variety of focal or nonfocal signs and symptoms
- Confusion, lethargy, memory loss, hemiparesis, aphasia, mental status changes, seizures
- Constitutional symptoms (systemic B symptoms)
Differential Diagnosis
Evaluation
- CT scan: well-defined focal lesion, isodense or hyperdense to the gray matter
- MRI scan (higher diagnostic yield): variable, isointense or hypointense lesions on T1-weighted images
- Lumbar puncture:
- CSF cytology
- CSF EBV PCR
- Should also obtain toxoplasma serologies, most are treated empirically for toxoplasma while serology is pending
- Stereotactic brain biopsy if necessary
Management
- High-dose methotrexate therapy (3 g/m2 for four to eight cycles)
- Steroids
- Potent antiretroviral therapy
- Radiation therapy
